The Children's Hospital Corporation, doing business as Boston Children's Hospital, has been awarded a 2-year, $125,658 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports research to unravel the mechanisms by which dietary saturated fatty acids influence platelet membrane composition and reactivity in the context of obesity-related cardiovascular complications. The project aims to determine how fatty acid uptake by platelets and megakaryocytes impacts platelet function, lipid raft content, and receptor signaling, with the goal of identifying new therapeutic targets and dietary interventions for managing obesity-associated thrombotic events. The research will be conducted at Boston Children's Hospital's facilities and is expected to be completed by June 30, 2026.
Generated 2/25/25, 5:45 AM